查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1645704

全球穩定同位素標記化合物市場（按類型、應用和最終用戶）- 機會分析和產業預測，2024 年至 2035 年

Stable Isotope Labeled Compounds Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 317 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

穩定同位素標記化合物市值預計在 2023 年達到 2.9182 億美元，到 2035 年將達到 4.201 億美元，2024 年至 2035 年的複合年成長率為 3.1%。

穩定同位素標記化合物是其中一個或多個原子被非放射性同位素取代的分子，例如碳-13（^13C）、氮-15（^15N）或氘（^2H）。這些同位素在化學上與自然界中的同位素相同，但原子質量不同，因此可以在不發射輻射的情況下進行追蹤。它們廣泛應用於研究和工業應用，在研究代謝途徑、藥物開發和環境過程方面發揮重要作用。由於它不具有放射性，因此可安全地用於生物和化學分析，並能為深入了解分子行為、反應機制和相互作用提供有價值的見解。

穩定同位素標記化合物市場的成長受到各種相互關聯的因素的顯著影響，這些因素增加了效用。對質譜和核磁共振（NMR）等先進分析技術日益成長的需求發揮著至關重要的作用。這些技術在很大程度上依賴穩定同位素標記化合物來實現精確的測量和高解析度的分析，從而促進它們的應用。隨著研究和診斷應用變得越來越複雜，對準確可靠的分析工具的需求也日益增加，進一步推動了市場的成長。此外，穩定同位素標記化合物在環境研究中的應用日益廣泛，凸顯了它們的多功能性。這些化合物用於追蹤污染物和監測環境變化，為監管和環境保護工作提供重要資料。這些應用將增加穩定同位素標記化合物在應對全球環境挑戰的重要性，從而推動市場成長。

穩定同位素標記化合物市場-IMG1

臨床試驗和蛋白質體學研究的擴展是另一個重要驅動力。穩定同位素標記化合物對於了解藥物代謝和生物系統內的複雜相互作用至關重要。在臨床試驗中，它有助於追蹤新藥的代謝途徑；在蛋白質體學中，它可以實現蛋白質的精確量化和追蹤。臨床和蛋白質組學應用的成長反映了人們越來越依賴這些化合物來推動醫學研究和個人化醫療。

此外，研究人員和臨床醫生對穩定同位素標記化合物的認知和採用不斷提高也是推動市場成長的主要因素。隨著研究人員和臨床醫生越來越熟悉穩定同位素標記化合物的優點，例如它們能夠提高各種研究的準確性和可靠性，這些化合物的使用正在增加。人們對此類穩定同位素標記化合物的價值的認知不斷提高，進一步促進了各個科學和臨床領域的需求增加，產生了推動整個市場成長的協同效應。

穩定同位素標記化合物市場分為類型、應用、最終用戶和地區。根據類型，市場分為氘、碳-13、氧-18、氮-15 和其他。根據應用，市場分為研究、臨床診斷和其他。研究部分進一步分為生物醫學研究、藥物研究和其他。根據最終用戶，市場細分為製藥和生物技術公司、學術和研究機構、醫院和診斷中心以及其他最終用戶。根據地區，市場分析涵蓋北美、歐洲、亞太、拉丁美洲、中東和非洲。

相關人員的主要利益

  • 本報告定量分析了 2023 年至 2035 年穩定同位素標記化合物市場分析的市場細分、當前趨勢、估計、趨勢和動態，並確定了突出的穩定同位素標記化合物市場機會。
  • 它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。
  • 波特五力分析強調了買家和供應商的潛力，使相關人員能夠做出利潤驅動的商業決策並加強供應商-買家網路。
  • 對穩定同位素標記化合物市場細分的詳細分析有助於發現市場機會。
  • 每個地區的主要國家都根據收益貢獻進行分類。
  • 市場公司的定位有利於基準化分析，並能清楚了解市場公司的當前地位。
  • 它包括對區域和全球穩定同位素標記化合物市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

此報告可進行客製化（需支付額外費用和時間表）

  • 國家、地區和全球層面的患者/流行病學資料
  • 監管指南
  • 根據客戶興趣提供額外的公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 擴展公司簡介列表
  • 歷史市場資料
  • SWOT 分析

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 關鍵影響因素
    • 重大投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 癌症發生率上升及研究進展
      • 增加政府資金和支持
      • 主要企業擴大採用這些策略
    • 限制因素
      • 製造成本高且技術複雜
    • 機會
      • 新興國家的成長機會

第4章。

  • 概述
  • 氘
  • 碳13
  • 氧氣 18
  • 氮 15
  • 其他

第5章穩定同位素標記化合物市場（依應用）

  • 概述
  • 研究
    • 穩定同位素標記化合物市場研究類型
  • 臨床診斷
  • 其他

第6章。

  • 概述
  • 製藥和生物技術公司
  • 學術和研究機構
  • 醫院和診斷中心
  • 其他

7. 穩定同位素標記化合物市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他
  • 拉丁美洲、中東和非洲
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品圖譜
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第9章 公司簡介

  • Merck KGaA
  • Otsuka Holdings Co., Ltd.
  • Entegris
  • Omicron Biochemicals, Inc.
  • Shimadzu Corporation
  • Silantes
  • VIVAN Life Sciences
  • BOC Sciences
  • Symeres
  • NIPPON SANSO HOLDINGS CORPORATION
簡介目錄
Product Code: A07585

The stable isotope labeled compounds market was valued at $291.82 million in 2023 and is estimated to reach $420.1 million by 2035, exhibiting a CAGR of 3.1% from 2024 to 2035. Stable isotope-labeled compounds are molecules where one or more atoms are replaced with non-radioactive isotopes, such as carbon-13 (^13C), nitrogen-15 (^15N), deuterium (^2H), and others. These isotopes are chemically identical to their naturally occurring counterparts but differ in atomic mass, allowing them to be tracked without emitting radiation. Widely used in research and industrial applications, they play a crucial role in studying metabolic pathways, drug development, and environmental processes. Their non-radioactive nature makes them safe for use in both biological and chemical analyses, providing valuable insights into molecular behavior, reaction mechanisms, and interactions at a detailed level.

The growth of the stable isotope-labeled compounds market is significantly influenced by a range of interconnected factors that enhance its utility across various fields. The rise in demand for advanced analytical techniques such as mass spectrometry and nuclear magnetic resonance (NMR) plays a pivotal role. These techniques rely majorly on stable isotope-labeled compounds to achieve precise measurements and high-resolution analysis, thus driving their adoption. The need for accurate and reliable analytical tools increases, as research and diagnostic applications become sophisticated, further fueling market growth. In addition, the increase in application of stable isotope-labeled compounds in environmental studies highlights their versatility. These compounds are used to trace pollutants and monitor environmental changes, providing crucial data for regulatory and conservation efforts. This application drives the growing importance of stable isotope-labeled compounds in addressing global environmental challenges, thus fostering the market growth.

Stable Isotope Labeled Compounds Market - IMG1

The expansion of clinical trials and proteomics studies represents another crucial driver. Stable isotope-labeled compounds are essential for understanding drug metabolism and the complex interactions within biological systems. In clinical trials, they help in tracing the metabolic pathways of new drugs, while in proteomics, they enable precise protein quantification and tracking. This growth in clinical and proteomics applications reflects the increasing reliance on these compounds for advancing medical research and personalized medicine.

Moreover, the rise in awareness and adoption of stable isotope-labeled compounds among researchers and clinicians is a key factor driving the market growth. There is an increase in the usage of these compounds as researchers and clinicians become familiar with the benefits associated with them, including their ability to enhance accuracy and reliability in various studies. This growing recognition of the value of stable isotope-labeled compounds further contributes to their increasing demand across diverse scientific and clinical fields, creating a synergistic effect that drives the overall market growth.

The stable isotope-labeled compounds market is segmented into type, application, end user, and region. On the basis of type, the market is segmented into Deuterium, Carbon-13, Oxygen-18, Nitrogen-15, and others. On the basis of application, the market is classified into research, clinical diagnostics, and other. The research segment is further divided into biomedical research, pharma research, and others. On the basis of end user, the market is categorized into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostic centers, and other end users. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Merck KGaA, Otsuka Holdings Co., Ltd., Entegris, Omicron Biochemicals, Inc., Shimadzu Corporation, Nippon Sanso Holding Corporation, Vivan Life Sciences, BOC Sciences, Silantes, and Symeres. The key players have adopted product launch, geographical expansion, partnership, and agreement as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the stable isotope labeled compounds market analysis from 2023 to 2035 to identify the prevailing stable isotope labeled compounds market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the stable isotope labeled compounds market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global stable isotope labeled compounds market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Deuterium
  • Carbon 13
  • Oxygen 18
  • Nitrogen15
  • Other

By Application

  • Research
    • Type
    • Biomedical Research
    • Pharma Research
    • Others
  • Clinical Diagnostics
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • BOC Sciences
    • Entegris
    • Merck KGaA
    • NIPPON SANSO HOLDINGS CORPORATION
    • Omicron Biochemicals, Inc.
    • Otsuka Holdings Co., Ltd.
    • Shimadzu Corporation
    • Silantes
    • Symeres
    • VIVAN Life Sciences

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in Cancer Prevalence and Advancements in Research
      • 3.4.1.2. Growing Government Funding and Support
      • 3.4.1.3. Rise in adoption of strategies by the key players
    • 3.4.2. Restraints
      • 3.4.2.1. High Production Costs and Technical Complexity
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth Opportunity in emerging countries

CHAPTER 4: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Deuterium
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Carbon 13
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Oxygen 18
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Nitrogen15
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Other
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Research
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Research Stable Isotope Labeled Compounds Market by Type
  • 5.3. Clinical Diagnostics
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Academic and Research Institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Hospitals and Diagnostic Centers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Merck KGaA
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Otsuka Holdings Co., Ltd.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Entegris
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Omicron Biochemicals, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Shimadzu Corporation
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Silantes
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. VIVAN Life Sciences
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. BOC Sciences
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Symeres
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. NIPPON SANSO HOLDINGS CORPORATION
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance